These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 426503)
21. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis. Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006 [TBL] [Abstract][Full Text] [Related]
23. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis. Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026 [TBL] [Abstract][Full Text] [Related]
24. Levels of antibiotic in human blood and interstitial fluid after oral administration of bacampicillin or phenoxymethyl penicillin and intravenous administration of amoxicillin or ampicillin. Tan JS; Salstrom SJ; File TM Rev Infect Dis; 1981; 3(1):121-4. PubMed ID: 6784223 [TBL] [Abstract][Full Text] [Related]
25. [Amoxicillin and its excretion into bronchial secretion (author's transl)]. Weingärtner L; Richter I; Patsch R; Thiemann HH; Brömme W; Baum W; Vorwald U Z Erkr Atmungsorgane; 1977 Feb; 147(2):186-98. PubMed ID: 899054 [TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis. Francke EL; Appel GB; Neu HC Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function. Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of amoxicillin and ampicillin: crossover study of the effect of food. Eshelman FN; Spyker DA Antimicrob Agents Chemother; 1978 Oct; 14(4):539-43. PubMed ID: 363052 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment. Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710 [TBL] [Abstract][Full Text] [Related]
32. Renal excretion of intravenously infused amoxycillin and ampicillin. Sjövall J; Westerlund D; Alván G Br J Clin Pharmacol; 1985 Feb; 19(2):191-201. PubMed ID: 3986077 [TBL] [Abstract][Full Text] [Related]
33. Effect of dose-concentration on the absorption of amoxicillin and ampicillin from the rat intestine. Tsuji A; Nakashima E; Kagami I; Honjo N; Yamana T J Pharm Pharmacol; 1977 Nov; 29(11):707-8. PubMed ID: 22611 [No Abstract] [Full Text] [Related]
34. Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers. Nilsson-Ehle I; Fellner H; Hedström SA; Nilsson-Ehle P; Sjövall J J Antimicrob Chemother; 1985 Oct; 16(4):491-8. PubMed ID: 4066561 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of cefepime in subjects with renal insufficiency. Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin. Davies BE; Boon R; Horton R; Reubi FC; Descoeudres CE Br J Clin Pharmacol; 1988 Oct; 26(4):385-90. PubMed ID: 3190988 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Horadam VW; Sharp JG; Smilack JD; McAnalley BH; Garriott JC; Stephens MK; Prati RC; Brater DC Ann Intern Med; 1981 Apr; 94(4 pt 1):454-8. PubMed ID: 7212501 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency. Patel IH; Bornemann LD; Brocks VM; Fang LS; Tolkoff-Rubin NE; Rubin RH Antimicrob Agents Chemother; 1985 Jul; 28(1):46-50. PubMed ID: 4037777 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment. Van der Auwera P; Stolear JC; George B; Dudley MN Antimicrob Agents Chemother; 1990 Aug; 34(8):1491-7. PubMed ID: 2221856 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function. Humbert G; Leroy A; Fillastre JP; Oksenhendler G Antimicrob Agents Chemother; 1978 Jul; 14(1):40-4. PubMed ID: 686708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]